List view / Grid view
14 June 2016 | By Victoria White, Digital Content Producer
The launch of Roche’s Tecentriq will usher in a dramatic change in the treatment paradigm of bladder cancer, according to an analyst with GlobalData...
14 June 2016 | By Victoria White, Digital Content Producer
Two studies of ertugliflozin, an investigational oral SGLT-2 inhibitor for the treatment of patients with type 2 diabetes, met their primary endpoints...
14 June 2016 | By Victoria White, Digital Content Producer
If approved, AF-219 would be the first new cough drug in 50 years and offer hope to the millions of people living with chronic cough...
14 June 2016 | By Victoria White, Digital Content Producer
Merck has announced results from two Phase III studies evaluating MK-1293 for the treatment of people with type 1 and type 2 diabetes...
14 June 2016 | By Victoria White, Digital Content Producer
The gang imported over 1.2 million unlicensed erectile dysfunction tablets and over 141,000 other illegal medicines including diazepam worth over £3.5 million...
Yusen Logistics has significantly strengthened its logistics presence in Duisburg; acquiring a new warehouse and expanding its storage capacity by 8,700 m². The total storage capacity of the multi-warehouse site is now 62,000 m².
13 June 2016 | By Victoria White, Digital Content Producer
Results showed improvement over chemotherapy on a number of measures including complete haematologic remission and progression-free survival...
13 June 2016 | By Victoria White, Digital Content Producer
A post-hoc analysis of the Phase III ASPIRE study highlighted the benefit of continued treatment with Kyprolis, lenalidomide and dexamethasone (KRd)...
13 June 2016 | By Victoria White, Digital Content Producer
New data for Jardiance (empagliflozin) show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes...
Results from Sanofi’s Phase III LixiLan-O and LixiLan-L clinical trials have been presented at the American Diabetes Association 76th Scientific Sessions.
13 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed the world's first safe and effective vaccine against toxic shock syndrome and successfully tested it in a Phase I trial...
Lilly has announced new findings from separate studies of Trulicity (dulaglutide) and Tradjenta (linagliptin) at the American Diabetes Association 76th Scientific Sessions.
13 June 2016 | By Victoria White, Digital Content Producer
Novo Nordisk presented new findings from separate studies of Tresiba and semaglutide at the American Diabetes Association 76th Scientific Sessions...
10 June 2016 | By Victoria White, Digital Content Producer
Merck, known as MSD outside the US and Canada, has announced that it is is to acquire Afferent Pharmaceuticals...
10 June 2016 | By Victoria White, Digital Content Producer
Amgen's Blincyto (blinatumomab) demonstrated an almost two-times increase in median overall survival compared to standard of care...
